Pediatric Surgery, University of Louisville, Louisville, KY 40202, USA.
J Pediatr Surg. 2012 Jun;47(6):1128-34. doi: 10.1016/j.jpedsurg.2012.03.017.
Endothelin-1, prostaglandins (PGs), and nitric oxide (NO) have been implicated in the intestinal microvascular dysfunction of necrotizing enterocolitis (NEC). We hypothesized that direct peritoneal resuscitation (DPR) dilates the intestinal microvasculature and improves blood flow independent of these mechanisms.
Rat pups were assigned by litter to experimental NEC or CONTROL groups. Laser Doppler flowmetry evaluation of intestinal microvascular blood flow was studied at baseline, with mediator blockade (endothelin-A receptor, endothelin-B receptor, PG synthesis, or NO synthase) and with DPR. Repeated-measures analysis of variance test was applied with Tukey-Kramer honestly significant difference test (P < .05).
At baseline, NEC animals demonstrated significantly decreased ileal blood flow as compared with CONTROLs (P < .05). Endothelin-A receptor and PG inhibition increased flow in the intestinal microvasculature, but this was significantly augmented by the addition of DPR (P < .05). Blockade of NO synthase decreased intestinal blood flow, which was overcome with addition of DPR (P < .05).
Ileal blood flow was significantly reduced in NEC animals as compared with CONTROLs. The addition of DPR to the peritoneum increased ileal blood flow significantly in all groups in spite of blockade of these known vasoactive mechanisms. Direct peritoneal resuscitation may be a novel strategy to improve intestinal blood flow in NEC.
内皮素-1、前列腺素(PGs)和一氧化氮(NO)被认为与坏死性小肠结肠炎(NEC)的肠道微血管功能障碍有关。我们假设直接腹膜复苏(DPR)可扩张肠道微血管并改善血流,而不依赖于这些机制。
通过窝别将大鼠幼崽分配到实验性 NEC 或对照组。使用激光多普勒血流仪评估肠道微血管血流,在基线时、在使用介质阻断(内皮素-A 受体、内皮素-B 受体、PG 合成或 NO 合酶)和 DPR 时进行研究。采用重复测量方差分析检验,并用 Tukey-Kramer 诚实显著差异检验(P<0.05)进行分析。
在基线时,与对照组相比,NEC 动物的回肠血流明显减少(P<0.05)。内皮素-A 受体和 PG 抑制增加了肠道微血管的血流,但 DPR 的加入显著增强了这种作用(P<0.05)。NO 合酶的阻断降低了肠道血流,而加入 DPR 则克服了这一作用(P<0.05)。
与对照组相比,NEC 动物的回肠血流明显减少。尽管阻断了这些已知的血管活性机制,但向腹膜内加入 DPR 可显著增加所有组的回肠血流。直接腹膜复苏可能是改善 NEC 肠道血流的一种新策略。